Allos Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of cancer. Allos Therapeutics reported the following financial data (in thousands) for three recent years:

a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one decimal place.
b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place.
c. Based on (a) and (b), comment on Allos Therapeutics' ratio of cash to monthly operating expenses for Year 3, Year 2, and Year1.

Transcribed Image Text:

For Years Ended December 31 Year 3 Cash and cash equivalents Net cash flows from operations 48,402 $141,423$ (63,656) Year 2Year 1 $30,696 (62,199 (42,850)